Penichet ML - Search Results

1

Decreased survival of human breast cancer cells expressing HER2/neu on in vitro incubation with an anti-HER2/neu antibody fused to C5a or C5a desArg.

Fuenmayor J, Perez-Vazquez K, Perez-Witzke D, Penichet ML, Montano RF. Fuenmayor J, et al. Among authors: penichet ml. Mol Cancer Ther. 2010 Aug;9(8):2175-85. doi: 10.1158/1535-7163.MCT-09-1054. Epub 2010 Aug 3. Mol Cancer Ther. 2010. PMID: 20682652

2

Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents.

Montano RF, Penichet ML, Blackall DP, Morrison SL, Chintalacharuvu KR. Montano RF, et al. Among authors: penichet ml. J Immunol Methods. 2009 Jan 1;340(1):1-10. doi: 10.1016/j.jim.2008.09.011. Epub 2008 Oct 9. J Immunol Methods. 2009. PMID: 18848836

3

Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein.

Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe ML, Morrison SL, Penichet ML, Kwon YG, Kim TW, Webster KA, Nechustan H, Shin SU. Cho HM, et al. Among authors: penichet ml. Mol Cancer Ther. 2005 Jun;4(6):956-67. doi: 10.1158/1535-7163.MCT-04-0321. Mol Cancer Ther. 2005. PMID: 15956253

4

Cytokines fused to antibodies and their combinations as therapeutic agents against different peritoneal HER2/neu expressing tumors.

Helguera G, Rodríguez JA, Penichet ML. Helguera G, et al. Among authors: penichet ml. Mol Cancer Ther. 2006 Apr;5(4):1029-40. doi: 10.1158/1535-7163.MCT-05-0488. Mol Cancer Ther. 2006. PMID: 16648575

5

Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer.

Fu M, Maresh EL, Helguera GF, Kiyohara M, Qin Y, Ashki N, Daniels-Wells TR, Aziz N, Gordon LK, Braun J, Elshimali Y, Soslow RA, Penichet ML, Goodglick L, Wadehra M. Fu M, et al. Among authors: penichet ml. Mol Cancer Ther. 2014 Apr;13(4):902-15. doi: 10.1158/1535-7163.MCT-13-0199. Epub 2014 Jan 21. Mol Cancer Ther. 2014. PMID: 24448822 Free PMC article.

6

A chaperone protein-enriched tumor cell lysate vaccine generates protective humoral immunity in a mouse breast cancer model.

Li G, Andreansky S, Helguera G, Sepassi M, Janikashvili N, Cantrell J, Lacasse CL, Larmonier N, Penichet ML, Katsanis E. Li G, et al. Among authors: penichet ml. Mol Cancer Ther. 2008 Mar;7(3):721-9. doi: 10.1158/1535-7163.MCT-07-2067. Mol Cancer Ther. 2008. PMID: 18347157

7

Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies.

Dela Cruz JS, Trinh KR, Chen HW, Ribas A, Morrison SL, Penichet ML. Dela Cruz JS, et al. Among authors: penichet ml. Mol Immunol. 2006 Feb;43(6):667-76. doi: 10.1016/j.molimm.2005.04.007. Mol Immunol. 2006. PMID: 15908002

8

The vitamin E analog, alpha-tocopheryloxyacetic acid enhances the anti-tumor activity of trastuzumab against HER2/neu-expressing breast cancer.

Hahn T, Bradley-Dunlop DJ, Hurley LH, Von-Hoff D, Gately S, Mary DL, Lu H, Penichet ML, Besselsen DG, Cole BB, Meeuwsen T, Walker E, Akporiaye ET. Hahn T, et al. Among authors: penichet ml. BMC Cancer. 2011 Nov 2;11:471. doi: 10.1186/1471-2407-11-471. BMC Cancer. 2011. PMID: 22044845 Free PMC article.

9

Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.

Karagiannis P, Singer J, Hunt J, Gan SK, Rudman SM, Mechtcheriakova D, Knittelfelder R, Daniels TR, Hobson PS, Beavil AJ, Spicer J, Nestle FO, Penichet ML, Gould HJ, Jensen-Jarolim E, Karagiannis SN. Karagiannis P, et al. Among authors: penichet ml. Cancer Immunol Immunother. 2009 Jun;58(6):915-30. doi: 10.1007/s00262-008-0607-1. Epub 2008 Oct 22. Cancer Immunol Immunother. 2009. PMID: 18941743 Free PMC article.

10

Conjugation of an anti transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells.

Daniels TR, Ng PP, Delgado T, Lynch MR, Schiller G, Helguera G, Penichet ML. Daniels TR, et al. Among authors: penichet ml. Mol Cancer Ther. 2007 Nov;6(11):2995-3008. doi: 10.1158/1535-7163.MCT-07-0330. Mol Cancer Ther. 2007. PMID: 18025284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page